AC Immune S.A. (ACIU)
NASDAQ: ACIU
· Real-Time Price · USD
2.11
-0.02 (-0.94%)
At close: Aug 18, 2025, 2:43 PM
AC Immune S.A. Cash Flow Statement
Financials in CHF. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -19.03M | -15.8M | 5.5M | -22.76M | -17.86M | -4.74M | -15.14M | -16.83M | -17.51M | -18.75M | -13.52M | -19.64M | -18.85M | -21.28M | -15.92M | -19.07M | -16.73M |
Depreciation & Amortization | 612K | 529K | 529K | 548K | 556K | 555K | 549K | 541K | 570K | 605K | 579K | 575K | 600K | 628K | 637K | 593K | 548K |
Stock-Based Compensation | 1.56M | 967K | 1.23M | 608K | 1.88M | 797K | 867K | 1.23M | 1.47M | 889K | 555K | 897K | 989K | 1.04M | 1.39M | 837K | 857K |
Other Working Capital | -1.62M | -1.73M | 489K | 91.73M | -64K | 165K | 570K | 167K | -1.26M | -4.22M | 2.68M | -855K | -5.9M | 3.42M | 3.77M | 1.19M | -1.53M |
Other Non-Cash Items | 339K | -2.13M | 2.78M | 3.41M | -2.03M | 1.32M | -211K | -45K | 138K | 234K | 62K | -388K | 20K | -1.64M | -4.38M | 444K | -615K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 506K | 171K | 530K | n/a | n/a | n/a | n/a | n/a | 4K | 10K | -22K | 138K |
Change in Working Capital | -2.3M | 22.36M | -24.18M | 91.22M | 18.11M | -14.62M | 467K | 462K | -1.47M | -386K | -1.22M | -924K | -5.9M | 3.42M | 3.77M | 1.19M | -1.53M |
Operating Cash Flow | -18.82M | 5.93M | -14.14M | 73.03M | 1.02M | -16.19M | -13.3M | -14.12M | -16.8M | -17.41M | -13.54M | -19.48M | -23.14M | -17.83M | -14.5M | -16.02M | -17.34M |
Capital Expenditures | -362K | -90K | -169K | -68K | -249K | -166K | -280K | -155K | -200K | -41K | -121K | -537K | -540K | -722K | -495K | -628K | -790K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 3.39M | -3.74M | -1.92M | -75.75M | -54K | 23.45M | 5M | -5M | 43M | 5M | -5M | 25M | n/a | -21M | n/a | -30.03M | n/a |
Investing Cash Flow | 3.03M | -3.83M | -2.09M | -75.82M | -23.56M | 23.28M | 4.72M | -5.16M | 42.8M | 4.96M | -5.12M | 24.46M | -540K | -21.72M | -495K | -30.66M | -790K |
Debt Repayment | -253K | -171K | -172K | -173K | -167K | -139K | -139K | -135K | -135K | -143K | -143K | -142K | -141K | 23.32M | -144K | -117K | -108K |
Common Stock Repurchased | -5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12K | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -1K | n/a | -24K | -523K | n/a | n/a | 2.05M | n/a | -8K | 1K | 5K | -775K | 1.08M | n/a | 137K | -125K |
Financial Cash Flow | -258K | -197K | -173K | -62K | -688K | 41.03M | 448K | 1.92M | -141K | -151K | -142K | -137K | -916K | 28.73M | 4.33M | -19K | 7.71M |
Net Cash Flow | -16.32M | 3.86M | -19.15M | -5.45M | -21.48M | 46.57M | -8.08M | -17.43M | 25.85M | -12.92M | -18.64M | 5.31M | -24.38M | -11.37M | -10.55M | -46.96M | -9.8M |
Free Cash Flow | -19.18M | 5.84M | -14.31M | 72.96M | 775K | -16.36M | -13.58M | -14.27M | -17M | -17.45M | -13.66M | -20.02M | -23.68M | -18.55M | -14.99M | -16.65M | -18.13M |